This interactive Web Seminar that explored various elements of the FDA’s Draft Guidance on Patient Reported Outcomess (PROs) in Clinical Research. During the one hour webinar, the scientific and regulatory experts of PRO Consulting also reviewed the answers to 10 questions often asked by clinical researchers, such as:
Presenter: Chad Gwaltney, Ph.D. - Scientist, PRO Consulting
Register to download the "How much do you know about the FDA's Draft PRO Guidance?", which was designed to help researchers make key decisions about the PRO strategy and instruments for clinical programs and individual trials.